MALDI-TOF Mass Spectrometry Imaging for Spatially Resolved Degradation Profiling of Solid Formulations
Analytical Chemistry · 29.10.2026
DOI: 10.1021/acs.analchem.6c03331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 29.10.2026. Verfasst von Rekha Thomas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of California, One Shields Avenue, Davis, California95616, United States. Hauptthemen laut MEDLINE: Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Losartan. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Genentech, University of California, Davis.
Abstract (Originalsprache)
Understanding the stability of the active pharmaceutical ingredient (API) and drug−excipient interactions is critical for ensuring the efficacy and shelf life of pharmaceutical formulations. This study applies matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to investigate two-dimensional (2D) and three-dimensional (3D) spatial profiling of degradants in Losartan potassium tablets that are subjected to temperature- and humidity-induced stress conditions. This approach allows for in situ visualization of API degradation and excipient compatibility within solid dosage forms. Upon stress, Losartan tablets formed dimeric and trimeric species as major degradation products. Spatial mapping revealed a gradual growth of these degradants from the control (T0) through four weeks of stress. Ion images showed distinct heterogeneity in the formation of dimer and trimer species across the tablet depth and plane; however, no preferential pattern was observed at the tablet periphery. The random distribution of degradants suggests that alongside humidity, localized microenvironments drive the degradation process. MALDI-MSI demonstrates strong potential as a high-throughput and sensitive alternative to traditional liquid chromatography-based procedures for early-stage formulation screening. Furthermore, this work suggests that when integrated with orthogonal techniques to coregister excipient domains, MALDI-MSI can serve as an emerging tool to uniquely characterize drug−excipient interactions during early-stage drug development. This provides spatially resolved insight that enhances accelerated stability assessment programs and streamline the selection of compatible excipients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of California, One Shields Avenue, Davis, California95616, United States.
- Genentech Inc., Synthetic Molecule Pharmaceutical Sciences (SMPS), South San Francisco, California94080, United States.
ORCID-Profile: Rekha Thomas, Christopher M Crittenden, Elizabeth K Neumann
Förderung
- Genentech
- University of California, Davis
Zitieren
APA
Thomas, R., Vargas, K. A., Shi, Z., Gruenhagen, J., Crittenden, C. M., & Neumann, E. K. (2026). MALDI-TOF Mass Spectrometry Imaging for Spatially Resolved Degradation Profiling of Solid Formulations. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c03331
Vancouver
Thomas R, Vargas KA, Shi Z, Gruenhagen J, Crittenden CM, Neumann EK. MALDI-TOF Mass Spectrometry Imaging for Spatially Resolved Degradation Profiling of Solid Formulations. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c03331
BibTeX
@article{Thomas2026,
author = {Thomas, Rekha and Vargas, Karina A and Shi, Zhenqi and Gruenhagen, Jason and Crittenden, Christopher M and Neumann, Elizabeth K},
title = {MALDI-TOF Mass Spectrometry Imaging for Spatially Resolved Degradation Profiling of Solid Formulations},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c03331}
}
EUVIMED